Home

Loading...

Table of contents

Vulvar intraepithelial neoplasia

Guidelines

Key sources

The following summarized guidelines for the evaluation and management of vulvar intraepithelial neoplasia are prepared by our editorial team based on guidelines from the British Gynaecological Cancer Society (BGCS 2020), the British Photodermatology Group (BPG/BAD 2019), and the American College of Obstetricians and Gynecologists (ACOG 2016). ...
Show more

Screening and diagnosis

Indications for screening: as per ACOG 2016 guidelines, insufficient evidence to recommend screening for vulvar high-grade squamous intraepithelial lesions (VIN usual type) for the prevention of vulvar cancer.
I
Create free account

Diagnostic investigations

Clinical assessment: as per ACOG 2016 guidelines, obtain a visual assessment for detection followed by histopathology for confirmation when needed.
E

Diagnostic procedures

Vulvar biopsy
As per ACOG 2016 guidelines:
Perform biopsy for visible vulvar lesions in the following situations:
definitive diagnosis cannot be made clinically
possible malignancy
presumed clinical diagnosis not responding to usual therapy
atypical vascular patterns
stable lesions rapidly changing in color, border, or size
E
Perform a biopsy in postmenopausal patients with apparent genital warts and in female patients of all ages with suspected condyloma if topical therapies have failed.
E

Medical management

Indications for treatment: as per ACOG 2016 guidelines, offer treatment in all patients with vulvar high-grade squamous intraepithelial lesions (VIN usual type).
E

More topics in this section

  • Topical imiquimod

  • Topical cidofovir

Therapeutic procedures

Laser ablation: as per ACOG 2016 guidelines, consider offering laser ablation as a treatment option in patients with vulvar high-grade squamous intraepithelial lesions (VIN usual type) if an occult invasion is not a concern.
E

More topics in this section

  • Photodynamic therapy

Surgical interventions

Surgical excision: as per BGCS 2020 guidelines, perform surgical excision as a treatment option in patients with high-grade VIN, recognizing that it has a ~50% response/recurrence rate by 12 months after treatment.
A

Preventative measures

Smoking cessation: as per ACOG 2016 guidelines, advise smoking cessation as it is strongly associated with vulvar high-grade squamous intraepithelial lesions (VIN usual type).
E

More topics in this section

  • HPV vaccination

Follow-up and surveillance

Follow-up
As per BGCS 2020 guidelines:
Obtain follow-up with careful clinical inspection with or without vulvoscopy in patients with high-grade VIN usual type.
B
Consider discharging patients with no recurrence of VIN usual type with access to rapid re-referral after 5 years.
C